The role of 99tcm-tetrofosmin in the evaluation of thyroid nodules

Nuclear Medicine Communications

Volumn 21, Issue 4, 2000, Pages 333-339

  Kanmaz, B ^a   Erdil, T Y ^a   Yardi, O F ^a   Sayman, H B ^a   Kabasakal, L ^a   SONMEZOGLU K ^a   ÖNSEL, Ç ^a   DUREN M ^a   Nisli, C ^a   OZCAN K ^a   Uslu, I ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOMA; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; SCINTISCANNING; THYROID NODULE; THYROID TUMOR;

ADENOMA; ADOLESCENT; ADULT; AGED; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROID NODULE;

EID: 0034171241     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200004000-00007     Document Type: Review

References (38)

1. Murray IPC, Steward RDH, Indyk JS. Thyroid scanning with Cs-131. Br Med J 1970; 4: 653-656.
2. Roos J, Schoot JB. The uptake of Ga-67 in euthyroid patients with multinodular goiter. Acta Med Scand 1973; 194: 225-228.
3. Tenvall J, Palmer J, Cederquist E et al. Scintigraphic evaluation and dynamic studies with thallium-201 in thyroid lesions with suspected cancer. Eur J Nucl Med 1981; 6: 295-300.
4. Harada T, Ito Y, Shimaoka K, Taniguchi T, Matsudo A, Senoo T. Clinical evaluation of thallium-201 chloride scan for thyroid nodule. Eur J Nucl Med 1980; 5: 125-130.
5. Bleichrodt RP, Vermey A, Piers A, Langen ZJ. Early and delayed thallium-201 imaging. Cancer 1987; 60: 2621-2623.
6. Ochi H, Sawa H, Fukuda T et al. Thallium-201-chloride thyroid scintigraphy to evaluate benign and/or malignant nodules: Usefulness of the delayed scan. Cancer 1982; 50: 236-240.
7. Ohnishi T, Noguchi S, Murakami N et al. Early and delayed imaging of Tc-99m HMPAO versus Tl-201 in benign and malignant thyroid tumors: Similar uptake but different retention. Clin Nucl Med 1992; 17: 806-811.
8. Derebek E, Biberoglu S, Kut Ö et al. Early and delayed thallium-201 scintigraphy in thyroid nodules: The relationship between early thallium uptake and perfusion. Eur J Nucl Med 1996; 23: 504-510.
9. Taillefer R, Lambert R, Dupras G et al. Clinical comparison between Tl-201 and Tc-99m methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989; 15: 280-286.
10. Iskandrian A, Heo J, Kong B et al. Use of technetium-99m-isonitrile (Rp-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease and comparison with coronary arteriography and exercise thallium-201 SPECT images. Am J Cardiol 1989; 64: 270-275.
11. Kiat H, Maddahi J, Roy L et al. Comparison of technetium-99m-methoxy-isobutyl-isonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1-11.
12. Vattimo A, Bertelli P, Burroni L. Effective visualisation of suppressed thyroid tissue by means of baseline methoxy-isobutyl-isonitrile in comparison with Tc-99m pertechnetate scintigraphy after TSH stimulation. J Nucl Biol Med 1992; 36: 315-318.
13. Földes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20: 330-333.
14. Geatti O, Shapiro B, Orsolon PG et al. Localisation of parathyroid enlargement: Experience with technetium-99m-methoxy-isobutyl-isonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 1994; 21: 17-22.
15. Vattimo A, Bertelli P, Burroni L et al. Single injection-dual phase scintigraphy with Tc-99m MIBI versus dual isotope (Tl-201-Tc-99m pertechnetate) study in the preoperative assessment of parathyroid adenoma. J Nucl Biol Med 1994; 38: 374-375.
16. Taillefer R, Boucher Y, Potvin C et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double phase study). J Nucl Med 1992; 23: 1801-1807.
17. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Identification of Hürthle cell tumor by single injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med 1995; 36: 778-781.
18. Özker K, Kabasakal L, Erdil TY et al. The value of late thallium and sestamibi imaging in differentiation of neoplastic and benign lesions of thyroid (abstract). Eur J Nucl Med 1993; 20: 293.
19. Basoğlu T, Sahin M, Coskun C, Koparan A, Bernay I, Erkan L. Technetium-99m-tetrofosmin uptake in malignant lung tumors. Eur J Nucl Med 1995; 22: 687-689.
20. Rambaldi PF, Mansi L, Procaccini E, Di Gregorio F, Del Vecchio E. Breast cancer detection with Tc-99m tetrofosmin. Clin Nucl Med 1995; 20: 703-705.
21. Nemec J, Nyvltova O, Preiningerova M et al. Positive thyroid cancer scintigraphy using Tc-99m-tetrofosmin (Myoview): A preliminary report. Nucl Med Commun 1995; 16: 694-697.
22. Klain M, Maurea S, Cuocolo A et al. Technetium-99m-tetrofosmin imaging in thyroid diseases: Comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans. Eur J Nucl Med 1996; 23: 1568-1574.
23. Aigner RM, Füger GF, Nicoletti R et al. Parathyroid scintigraphy: Comparison of technetium-99m methoxyisobutylisonitrile and technetium-99m tetrofosmin studies. Eur J Nucl Med 1996; 23: 693-696.
24. Kosuda S, Yokoyama H, Katayama M et al. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma. J Nucl Med 1995; 22: 1218-1220.
25. Gobien RP. Aspiration biopsy of solitary thyroid nodule. Radiol Clin North Am 1979; 17: 543-554.
26. Solbiati L, Volterrani L, Rizzato G et al. The thyroid gland with low uptake lesions: Evaluation by ultrasound. Radiology 1985; 155: 187-191.
27. Kaplan WD, Holman L, Selenkiw HA et al. Ga-67-citrate and the nonfunctioning thyroid nodule. J Nucl Med 1974; 15: 424-427.
28. Hardoff R, Baron E, Sheinfeld M. Early and late lesion-to-nonlesion ratio of thallium-201-chloride uptake in the evaluation of ‘cold’ thyroid nodules. J Nucl Med 1991; 32: 1873-1876.
29. Henze E, Roth J, Boerer H et al. Diagnostic value of early and delayed Tl-201 thyroid scintigraphy in the evaluation of cold nodules for malignancy. Eur J Nucl Med 1986; 11: 413-416.
30. Sundram FX, Mack P. Evaluation of thyroid nodules for malignancy using Tc-99m-sestamibi. Nucl Med Commun 1995; 16: 687-689.
31. Kresnik E, Gallowich HJ, Mikosch P et al. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy. Eur J Nucl Med 1997; 24: 716-721.
32. Ballinger JR, Bannerman J, Boxen I, Firby F, Hartman NG, Moore MJ. Technetium-99m tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug resistant breast tumor cells. J Nucl Med 1996; 37: 1578-1582.
33. Crankshaw CL, Marmion M, Luker GD et al. Novel technetium [III]-Q complexes for functional imaging of multidrug resistance [MDR1] P-glycoprotein. J Nucl Med 1998; 39: 77-86.
34. Pavoni P, Mango L. Clinical evaluation of 201-Thallium chloride scan for thyroid nodule. Eur J Nucl Med 1981; 6: 47-49.
35. McDonald RJ, Wu S, Jensen JL et al. Malignant tranformation of a Hürthle cell tumor: Case report and survey of the literature. J Nucl Med 1991; 32: 1266-1269.
36. Rosai J. Thyroid gland. In: Rosai J, ed. Ackerman’s surgical pathology. New York: Mosby, 1996: 493-561.
37. Oertel JE, Li Volsi VA. Pathology of thyroid diseases. In: Ingbar SH, Braverman LE, eds. Werner’s the thyroid, 5th edn. Philadelphia, PA: J.B. Lippincott, 1986: 651-686.
38. Li Volsi VA, Montone K, Sack M. Pathology of thyroid disease. In: Sternberg SS, ed. Diagnostic surgical pathology, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 1999: 529-587.